ACT Genomics will present precision medicine and cancer genomic profiling services at R224 in Taiwan Healthcare+ Expo from 12/05-12/08
Place:
Taipei
ACTGenomics presents precision medicine and cancer genomic profiling services at M228 in BioAsia-Taiwan. Welcome to visit us.
Place:
Taipei
Chief Scientific Officer Dr. Shu Jen Chen will be presenting on "Biomarker Solution for Immunotherapy: TMB and Beyond" at the 16th PMWC on Jan 22nd, focusing on TMB and Tumor Micro-environment.
Place:
Silicon Valley, CA
ACT Genomics and Taiwan Lung Cancer Society will hold Asia Pacific Lung Cancer Forum on November 28th at Taipei W hotel.
Place:
Taipei
ACT Genomics has the invaluable opportunity to be one of the sponsors of the 5th Hong Kong International Oncology Symposium (5th HKIOS) from 10th -11th November 2018 at Hong Kong Science and Technology Park (HKSTP) and City University of Hong Kong (CityU)
Place:
Hong Kong
MB Harmonization oral presentation titled “In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project “ is scheduled on November 9 th
Place:
USA
ACT Genomics introduced how innovative genomic profiling services can improve immunotherapy reponse rate with predictive biomarkers such as tumor mutational burden (TMB) in The 33rd Annual Meeting & Pre-Conference Programs (SITC 2018)
Place:
USA
Dr. Timothy T.C. Yip delivered a talk titled “The New Frontier in Precision Oncology Treatment: How Next-Generation Sequencing (NGS) testing can guide the use of targeted & immune drugs in treatment of cancer patients?”
Place:
Hong Kong
ACT Genomics is proudly sponsoring a medical talk to be given by Dr. Li Yu Chung, Jacky, consultant and specialist in Clinical Oncology from Hong Kong United Oncology Centre
Place:
Hong Kong
ACT Genomics was honoured to be invited to give a scientific talk at Gleneagles Medini Hospital, Johor, Malaysia on 30th October 2018.
Place:
Malaysia